Jeffrey W. Sherman, M.D., FACP
2018
Compensation breakdown
| Non-Equity Incentive Plan | $533,670 |
|---|---|
| Salary | $543,250 |
| Stock Awards | $2,533,691 |
| Other | $68,263 |
| Total | $3,678,874 |
FACP received $2.5M in stock awards, accounting for 69% of the total pay in 2018.
FACP also received $533.7K in non-equity incentive plan, $543.3K in salary and $68.3K in other compensation.
Rankings
In 2018, Jeffrey W. Sherman, M.D., FACP's compensation ranked 3,061st out of 14,244 executives tracked by ExecPay. In other words, FACP earned more than 78.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,061 out of 14,244 | 79th |
Division Manufacturing | 1,130 out of 5,758 | 80th |
Major group Chemicals And Allied Products | 390 out of 2,119 | 82nd |
Industry group Drugs | 320 out of 1,808 | 82nd |
Industry Pharmaceutical Preparations | 244 out of 1,382 | 82nd |
Pay ratio
| Jeffrey W. Sherman, M.D., FACP's Pay | $3,678,874 |
|---|---|
| Median Employee's Pay | $207,196 |
| Pay Ratio | to 1 |
In 2018, the annual total compensation of Jeffrey W. Sherman, M.D., FACP was $3,678,874.
The annual total compensation of the median employee at Horizon Pharma was $207,196.
The ratio of Jeffrey W. Sherman, M.D., FACP's pay to the pay of median employee was therefore to one.
FACP's colleagues
We found six more compensation records of executives who worked with Jeffrey W. Sherman, M.D., FACP at Horizon Pharma in 2018.
2018
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2018
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2018
Robert Carey
Horizon Pharma
Executive Vice President, Chief Business Officer
2018
Shao-Lee Lin
Horizon Pharma
Chief Scientific Officer
2018
Barry Moze
Horizon Pharma
Chief Administrative Officer
2018
Vikram Karnani
Horizon Pharma
Executive Vice President, Chief Commercial Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019